Evidence map›Paper›PMID 27256482›Full record

ReviewMolecular human reproduction2016

Preimplantation genetic screening 2.0: the theory.

Joep Geraedts, Karen Sermon

Registry-linked trialAbstract readReview
In one paragraph

Review in Molecular human reproduction, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02902614 (Effect of Embryo Biopsy Side on Post Biopsy Blastocyst Structurs and Implantation), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02902614 nacompletednot on this map

Effect of Embryo Biopsy Side on Post Biopsy Blastocyst Structurs and Implantation

TypeinterventionalSponsorAhmad Mustafa Mohamed MetwalleyRan2015 to 2018Enrolled100ConditionsPreimplantation DiagnosisArmsVegetal Pole blastomer embryo, Animal Pole blastomer embryo
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Extended application of PGT-M strategies for small pathogenic CNVs.Journal of assisted reproduction and genetics · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Joep GeraedtsGROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands joep.geraedts@mumc.nl.
Karen SermonResearch Group Reproduction and Genetics, Vrije Universiteit Brussel, Laarbeeklaan 101, Brussels 1090, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the last few years a new generation of preimplantation genetic screening (PGS) has been introduced. In this paper, an overview of the different aspects of this so-called PGS 2.0 with respect to the why (what are the indications), the when (which developmental stage, i.e. which material should be studied) and the how (which molecular technique should be used) is given. With respect to the aims it is clear that PGS 2.0 can be used for a variety of indications. However, the beneficial effect of PGS 2.0 has not been proved yet in RCTs. It is clear that cleavage stage is not the optimal stage for biopsy. Almost all advocates of PGS 2.0 prefer trophectoderm biopsy. There are many new methods that allow the study of complete aneuploidy with respect to one or more of the 24 chromosomes. Because of the improved vitrification methods, selection of fresh embryos for transfer is more and more often replaced by frozen embryo transfer. The main goal of PGS has always been the improvement of IVF success. However, success is defined by different authors in many different ways. This makes it very difficult to compare the outcomes of different studies. In conclusion, the introduction of PGS 2.0 will depend on the success of the new biopsy strategies in combination with the analysis of all 24 chromosomes. It remains to be seen which approach will be the most successful and for which specific groups of patients.

Indexed as

AneuploidyBiopsyComparative Genomic HybridizationEmbryo TransferFemaleGenetic TestingHumansPregnancyPreimplantation Diagnosisaneuploidyarray comparative genomic hybridizationblastocyst biopsyblastomere biopsychromosomal abnormalitiescomprehensive chromosome screeningpolar body biopsypreimplantation genetic screening

Identifiers

PMID27256482
PMCPMC4986416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.